Technology Calls Page 725

Showing 10861 to 10875 of 21923 results

Thomas Schmitt

Marketing at Creative Diagnostics

0 publications

Thomas Schmitt posted this: Article:

Marketing at Creative Diagnostics

Respiratory Syncytial Virus Antigens and Antibodies for Vaccine Development

Respiratory syncytial virus (RSV) is a very contagious virus that causes a respiratory tract infection, affecting 64 million people per year worldwide. Currently, there is no licensed vaccine to prevent RSV infections. The only FDA approved treatment option is a humanized monoclonal antibody (IgG) against the RSV fusion protein, known as palivizumab. Creative Diagnostics has released a range of respiratory syncytial virus antibodies and antigen...

Article

+3 weeks

Thomas Schmitt

Marketing at Creative Diagnostics

0 publications

Thomas Schmitt posted this: Article:

Marketing at Creative Diagnostics

Native Antigens for Vaccine R&D

Our range of vaccine R&D reagents include more than 40 native antigens of key infectious pathogens, including Corynebacterium diphtheriae, Clostridium tetani, Enterovirus, Hepatitis virus, Influenza virus, Poliovirus, Rotavirus, Streptococcus pneumoniae, and Zika virus. These native antigens for vaccine can be used in a variety of applications, from the development of conjugate vaccines, to the evaluation of vaccination efficacy by antibody test...

Article

+3 weeks

Dianna Gellar

Marketing Manager at CD Genomics

8 publications

Dianna Gellar posted this: Article:

Marketing Manager at CD Genomics

Comparison Between Illumina and Nanopore Sequencing Technologies

What is Illumina Sequencing? Illumina sequencing is a second-generation sequencing technology that has become a powerful tool for genomics research. The method uses reversible dye terminator technology to detect the sequence of a DNA molecule. The process begins by fragmenting the DNA sample into short fragments, typically 100-150 base pairs (bp) in length. These fragments are then ligated to a universal adapter and annealed to a slide. Polyme...

Article

+3 weeks

Alejandro De La Parra-Solomon

Senior Entrepreneur based in Tallinn, Estonia focused on Information Technology, Education, Health, International Trade, and Real Estate.

0 publications

Alejandro De La Parra-Solomon posted this: Article:

Senior Entrepreneur based in Tallinn, Estonia focused on Information Technology, Education, Health, International Trade, and Real Estate.

Artificial Intelligence in Overdrive: The Rise of AGI

Artificial Intelligence in Overdrive: The Rise of AGI ✨ OpenAI has embarked on a transformative journey, aiming to usher in a new era of technology. This journey revolves around the development of Artificial General Intelligence (AGI) and the creation of AI agents that possess median human intelligence. OpenAI's shift towards AGI and these advanced agents marks a pivotal moment in the tech industry. AGI, often dubbed as the holy grail...

Article

+3 weeks

Jim Zhan

Other at RPWORLD

0 publications

Jim Zhan posted this: Article:

Other at RPWORLD

Unlocking Design Potential with CNC Machining: A Guide to Enhancing Product Development

In the realm of product development, turning innovative designs into tangible prototypes or final products is a crucial step. CNC machining is an important process that allows designers to push the boundaries and transform their design ideas into reality. Let’s find out how CNC machining can accelerate product development. Unleashing Design Freedom: CNC machining offers unparalleled design freedom, allowing designers to create intricate a...

Article

+3 weeks

Caihong Zhang

CEO at KMD Bioscience Co., Ltd.

0 publications

Caihong Zhang posted this: Article:

CEO at KMD Bioscience Co., Ltd.

KMD Bioscience-Antibody Generation Techniques: Polyclonal vs. Monoclonal

Antibodies, as pivotal components of the immune system, have been employed in various scientific and medical fields. The generation of antibodies, as a critical aspect of immunological responses, has garnered significant attention in biomedical research and clinical applications. The methodologies for producing antibodies can be broadly categorized into polyclonal and monoclonal approaches, each with distinct protocols and resultant antibody popu...

Article

+3 weeks

Ishanvi Navnidhi

Program Manager at Inovine Meetings LLC

0 publications

Ishanvi Navnidhi posted this Event:

Program Manager at Inovine Meetings LLC

8th Global Summit on Diabetes and Obesity 2024

29 - 30 July, 2024

Hyatt Place London Heathrow Airport, UK

INOVINE Scientific meetings is overwhelmed to announce the commencement of “8th Global Summit on Diabetes & Obesity” to be held during July 29-30,2024| London, UK. The upcoming conference will be organized around the theme “Innovations in the field of Diabetes & Obesity Procedures and Treatment”. The main objective of Diabetes congress 2024 is to promote awareness about diabetes and risk associated w...